PCRX Pacira Net Sales Margin

Pacira Pharmaceuticals (PCRX) - corporate logo

Pacira BioSciences (PCRX) is recognized as the benchmark in safe pain management, offering surgeons a reliable alternative to opioids. Investments in advanced liposomal drug delivery systems provide high potential. The company is currently normalizing its finances by adapting pricing to generic competition. The operating net sales margin demonstrates the current efficiency of the model, where its value is 5.10, determining the asset's investment attractiveness.

Pacira Corp (PCRX) Net Profit Rate: for the period 07/04/2022 - 11/19/2026

Pacira (PCRX) - metric breakdowns and financial figures

- share price and expert price forecast:
Fundamental valuation:Pacira Pharmaceuticals - PCRX
Finished products of Pacira Pharmaceuticals

Exparel's expansion as part of the fight against the opioid crisis in the US and the broadening of pediatric indications establish a foundation for high operational efficiency at Pacira BioSciences (PCRX). By analyzing the net profit margin, an investor can see the profit share of every dollar of revenue, which allows for a real-time assessment to differentiate the business's true financial stability from temporary fluctuations in quarterly reporting.

Competitors of Pacira BioSciences (PCRX)

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Return on Sales by Net Profit ARS Pharmaceuticals, Inc. (SPRY)|Net Sales Margin TBPH|AQST (Aquestive Therapeutics) - Net Profit Rate|scPharmaceuticals, Inc. - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma